Search Results 681-690 of 17019 for pharmacogenetics
This population will be queried for biologic use prior to age 18. The study population for the remainder of the study will be all CD and UC patients in ICN who ...
Magnetic Resonance: Stephen J. · Melanoma Research: Svetomir N. · Membrane Trafficking in Disease: Mark A. · Memory Disorders: Neill R. · Meningeal Lymphatics and ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...
Statins can save lives, are they being used? · Answers to common questions about whether vaccines are safe, effective and necessary featured image · Science ...
The Mayo Clinic Breast Cancer SPORE supports translational research projects on genetic mutations, Z-endoxifen and p95HER2 in HER2+ breast cancer.
The purpose of this study is to gather survey data on willingness to engage in an online community for biomedical research among adults statewide in Minnesota.
As a pulmonologist and genomic scientist, Victor Ortega, M.D., Ph.D., is leading a charge to breathe new life into precision medicine advancements. His mission ...
About this study. This is a study of TRC105 in combination with standard dose pazopanib compared to single agent pazopanib in patients with angiosarcoma not ...
About this study. This phase II trial studies fluorothymidine F 18 (FLT) positron emission tomography (PET)/computed tomography (CT) in measuring response ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.